Production of recombinant human retinal antigens for the study of lymphocyte reactivity in endogenous posterior uveitis
Endogenous posterior uveitis (EPU) is currently treated with immunosuppressive drugs, the uses of which are limited by systemic side effects and the development of refractoriness towards the treatment. EPU is thought to be the result of an autoimmune response towards sequestered antigens in the reti...
Main Author: | Hewick, Simon A. |
---|---|
Published: |
University of Aberdeen
2003
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.401399 |
Similar Items
-
The medical aspects of endogenous uveitis
by: Inch, Robert Stuart Malcolm Douglas
Published: (1957) -
Analysis of candidate retinal autoantigens in autoimmune uveitis
by: Morgan, James
Published: (2005) -
Le décor de stuc à Damas à l'époque des Zanguides et des Ayyoubides
by: Abbas, Howaida
Published: (2018) -
Retinal vascular involvement in uveitis and new treatment options
by: Shirodkar, A.
Published: (2013) -
Genetics of chemokines & cytokines in non-infectious posterior segment uveitis
by: Ahad, M. A.
Published: (2013)